Surgical Advances in Paediatric Neuroblastoma

A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Surgery".

Deadline for manuscript submissions: closed (20 April 2021) | Viewed by 9330

Special Issue Editor


E-Mail Website
Guest Editor
DiNOGMI, University of Genova – G. Gaslini Children’s Hospital, 16126 Genoa, Italy
Interests: neuroblastoma; paediatric oncology; neurocristopathies; Hirschsprung disease

Special Issue Information

Dear Colleagues,

This Special Issue’s primary focus is on the diagnosis, management, and surgical treatments of patients with neuroblastoma (NB), the most common extracranial solid tumor in children.

It counts for up to 8–10% of all childhood malignancies and approximately 15% of all cancer-related deaths in the pediatric population.  

With at least one-third of patients presenting with metastases at diagnosis, NB represents one of the most challenging diseases for pediatric oncologists and surgeons. In fact, despite the development of new treatment options, the prognosis of high-risk NB patients remains poor with long-term survival of less than 50%. 

In literature, several reports and metanalyses highlight the importance of an appropriate diagnosis and more aggressive surgical resections to improve local tumor control and survival outcomes in children with both localized and metastatic NBs.

However, performing a radical tumor resection in NB is particularly challenging for the surgeon; this is because NB tumors grow into the deepest part of the abdominal and/or thoracic cavities and envelop the main vessels and nerves in the body, and they develop tight adhesions to the organs (kidneys, liver, pancreas, etc.). 

Therefore, novel approaches that could assist surgeons to perform a complete tumor excision and to easily identify malignant cells versus normal anatomical structures or necrotic/scar tissues are desperately needed in pediatric surgery.

For this reason, it is important to highlight current managements and surgical approaches for neuroblastoma treatment in order to support clinicians and surgeons in performing a correct diagnosis that will allow the implementation of appropriate treatment strategies.

Prof. Giuseppe Martucciello
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Neuroblastoma 
  • Neurocristopathy 
  • Pediatric oncology 
  • Surgery 
  • Surgical approaches 
  • Immunotherapy 
  • MYCN

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Review

3 pages, 177 KiB  
Editorial
Surgical Advances in Paediatric Neuroblastoma
by Giuseppe Martucciello
Children 2022, 9(5), 663; https://0-doi-org.brum.beds.ac.uk/10.3390/children9050663 - 05 May 2022
Viewed by 1013
Abstract
As an introduction to this “Special Issue” launched by Children (ISSN 2227-9067), I would firstly like to highlight those neoplasms should be labeled with the more appropriate term “Neuroblastomas” (NBs) [...] Full article
(This article belongs to the Special Issue Surgical Advances in Paediatric Neuroblastoma)

Review

Jump to: Editorial

15 pages, 2595 KiB  
Review
Novel Treatments and Technologies Applied to the Cure of Neuroblastoma
by Irene Paraboschi, Laura Privitera, Gabriela Kramer-Marek, John Anderson and Stefano Giuliani
Children 2021, 8(6), 482; https://0-doi-org.brum.beds.ac.uk/10.3390/children8060482 - 07 Jun 2021
Cited by 15 | Viewed by 3654
Abstract
Neuroblastoma (NB) is the most common extracranial solid tumour in childhood, accounting for approximately 15% of all cancer-related deaths in the paediatric population1. It is characterised by heterogeneous clinical behaviour in neonates and often adverse outcomes in toddlers. The overall survival of children [...] Read more.
Neuroblastoma (NB) is the most common extracranial solid tumour in childhood, accounting for approximately 15% of all cancer-related deaths in the paediatric population1. It is characterised by heterogeneous clinical behaviour in neonates and often adverse outcomes in toddlers. The overall survival of children with high-risk disease is around 40–50% despite the aggressive treatment protocols consisting of intensive chemotherapy, surgery, radiation therapy and hematopoietic stem cell transplantation2,3. There is an ongoing research effort to increase NB’s cellular and molecular biology knowledge to translate essential findings into novel treatment strategies. This review aims to address new therapeutic modalities emerging from preclinical studies offering a unique translational opportunity for NB treatment. Full article
(This article belongs to the Special Issue Surgical Advances in Paediatric Neuroblastoma)
Show Figures

Graphical abstract

11 pages, 216 KiB  
Review
Anesthesia in Children with Neuroblastoma, Perioperative and Operative Management
by Costanza Tognon, Rebecca Pulvirenti, Federica Fati, Federica De Corti, Elisabetta Viscardi, Andrea Volpe and Piergiorgio Gamba
Children 2021, 8(5), 395; https://0-doi-org.brum.beds.ac.uk/10.3390/children8050395 - 14 May 2021
Cited by 2 | Viewed by 3811
Abstract
Neuroblastoma (NB) is the most common extracranial, solid, pediatric malignancy and, despite the constant progress of treatment and development of innovative therapies, remains a complex, challenging disease causing major morbidity and mortality in children. There is significant variability in the management of neuroblastoma, [...] Read more.
Neuroblastoma (NB) is the most common extracranial, solid, pediatric malignancy and, despite the constant progress of treatment and development of innovative therapies, remains a complex, challenging disease causing major morbidity and mortality in children. There is significant variability in the management of neuroblastoma, partially due to the heterogeneity of the clinical and biological behavior, and partially secondary to the different approaches between treating institutions. Anesthesia takes an integral part in the multidisciplinary care of patients with NB, from diagnosis to surgery and pain control. This paper aims to review and discuss the critical steps of the perioperative and operative management of children undergoing surgery for neuroblastoma. Anesthesia and analgesia largely depend on tumor location, surgical approach, and extension of the surgical dissection. Attention should be paid to the physio-pathological changes on cardiovascular, gastrointestinal, and immune systems induced by the tumor or by chemotherapy. At the time of surgery meticulous patient preparation needs to be carried out to optimize intraoperative monitoring and minimize the risk of complications. The cross-sectional role of anesthesia in cancer care requires effective communication between all members of the multidisciplinary team. Full article
(This article belongs to the Special Issue Surgical Advances in Paediatric Neuroblastoma)
Back to TopTop